Do tobacco and cannabis use and co-use predict lung function: A longitudinal study.

Area of Science:

• Respiratory Medicine
• Public Health
• Adolescent Health

Background:

• Tobacco and cannabis use are prevalent in young adults.
• Their combined impact on lung function during this developmental period is not well understood.
• Previous research suggests tobacco use predicts lung function, but cannabis co-use effects are less clear.

Purpose of the Study:

• To investigate the association between cigarette smoking, cannabis use, and their co-use with lung function in young adults.
• To determine if co-use confers additional risks beyond individual substance use.
• To analyze changes in lung function (FVC, FEV1, FEV1/FVC) from age 21 to 30.

Main Methods:

• Prospective cohort study design.
• Data collected from individuals at ages 21 and 30, including spirometry assessments and questionnaires on smoking and cannabis habits.
• Lung function parameters analyzed using Global Lung Function Formulae.

Main Results:

• Cigarette smoking, irrespective of concurrent cannabis use, was associated with reduced airflow.
• No consistent association was found between cannabis use alone and lung function measures.
• Co-use of tobacco and cannabis did not demonstrate increased lung function risk compared to tobacco use alone.

Conclusions:

• Persistent cigarette smoking is linked to diminished lung airflow in young adults.
• Cannabis use, even over extended periods, does not appear to significantly impact lung function.
• Findings suggest tobacco use is the primary driver of airflow reduction in this population, with co-use not exacerbating the effect.